BBNX

Beta Bionics, Inc. - Common Stock (BBNX)

About Beta Bionics, Inc. - Common Stock (BBNX)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Details

Daily high

$17.51

Daily low

$14.54

Price at open

52 Week High

$32.71

52 Week Low

$8.80

Market cap

921.5M

Dividend yield

Volume

117

Avg. volume

1.1M

P/E ratio

-9.18

Beta Bionics, Inc. - Common Stock News